Michigan 2025-2026 Regular Session

Michigan House Bill HB5108

Introduced

10/22/25

Refer

10/22/25

Caption

Health occupations: pharmacists; pharmacist scope of practice; modify. Amends secs. 5111, 17703, 17707, 17708, 17724a, 17744, 17744a, 17751, 17757 & 17763 of 1978 PA 368 (MCL 333.5111 et seq.) & adds sec. 17744h.

Impact

The proposed amendments are anticipated to significantly enhance the role of pharmacists in patient care, allowing them to perform qualified laboratory tests and prescribe medications based on the outcomes of these tests. This change is expected to improve immediate healthcare access for patients, reduce the burdens on primary care providers, and streamline the response to public health threats. Moreover, the legislation aligns with National trends advocating for the maximization of healthcare workforce efficiencies by utilizing pharmacists more effectively.

Summary

House Bill 5108 proposes amendments to the Public Health Code of Michigan aimed at expanding the scope of practice for pharmacists. Specifically, it modifies several sections of the code concerning the reporting and management of communicable diseases, as well as the authority of pharmacists to prescribe certain medications following clinical assessments. The bill emphasizes the importance of pharmacists in providing timely care and addresses the growing need for accessible healthcare solutions, especially in light of public health emergencies like the COVID-19 pandemic.

Contention

However, debates surrounding this bill include concerns about the training and qualifications of pharmacists in performing diagnostic tests and issuing prescriptions. Critics argue that while expanding pharmacists' roles can improve healthcare access, there are fears regarding patient safety and the risk of inappropriate medication use without proper medical oversight. The various stakeholders, including healthcare professionals and patient advocacy groups, appear divided over whether the benefits outweigh the risks associated with these proposed changes.

Companion Bills

No companion bills found.

Previously Filed As

MI HB5050

Health: pharmaceuticals; administration of epinephrine; modify. Amends secs. 17744a & 17744d of 1978 PA 368 (MCL 333.17744a & 333.17744d). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5051'25, HB 5052'25, HB 5053'25

MI SB0401

Health: pharmaceuticals; co-prescribing of naloxone with opioid drugs; require. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b).

MI HB5354

Health: pharmaceuticals; authority of certain physicians issuing standing orders; provide for. Amends secs. 9204 & 17744e of 1978 PA 368 (MCL 333.9204 & 333.17744e).

MI HB5446

Health occupations: health professionals; licensure of naturopathic doctors; provide for. Amends secs. 16265, 17708 & 18001 of 1978 PA 368 (MCL 333.16265 et seq.) & adds sec. 16348a & pt. 186.

MI HB4932

Health occupations: pharmacists; continuing education requirements for pharmacists and pharmacy technicians; modify. Amends sec. 17731 of 1978 PA 368 (MCL 333.17731).

MI SB0384

Health: pharmaceuticals; delivery of prescription drugs associated with medically assisted treatment programs in county jails; allow. Amends sec. 17745a of 1978 PA 368 (MCL 333.17745a).

MI HB4252

Health: pharmaceuticals; labeling of generic name on pharmaceutical blister packaging; require under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17748g.

MI SB0516

Health: pharmaceuticals; ivermectin; allow over-the-counter access. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding secs. 17771 & 17771a.

MI HB4837

Health: pharmaceuticals; ivermectin; allow over-the-counter access. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding secs. 17771 & 17771a.

MI HB5826

Health: occupations; licensing sanctions for compliance with death with dignity act; prohibit under certain circumstances. Amends secs. 17752 & 20175 of 1978 PA 368 (MCL 333.17752 & 333.20175) & adds 16221c. TIE BAR WITH: HB 5825'26

Similar Bills

NJ S968

Requires insurers offering commercial general liability insurance policies to provide notification of exclusion for communicable disease.

MN HF292

Tamarack; resurfacing local roads funding provided, bonds issued, and money appropriated.

MN HF394

Limits for contact tracing, digital contract tracing, immunizations, communicable disease testing, and the required disclosure of certain information established; destruction of certain data required; mandatory digital contact tracing by employers prohibited; and civil penalties provided.